Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition.
about
A reversible light-operated nanovalve on mesoporous silica nanoparticles.Rapid endosomal escape of prickly nanodiamonds: implications for gene delivery.Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery.Unambiguous observation of shape effects on cellular fate of nanoparticles.An overview of nanosomes delivery mechanisms: trafficking, orders, barriers and cellular effects.Cellular uptake of nanoparticles: journey inside the cell.Nanotoxicology: advances and pitfalls in research methodology.Breakable mesoporous silica nanoparticles for targeted drug delivery.Excess titanium dioxide nanoparticles on the cell surface induce cytotoxicity by hindering ion exchange and disrupting exocytosis processes.Immunogold labeling reveals subcellular localisation of silica nanoparticles in a human blood-brain barrier model.A free-blockage controlled release system based on the hydrophobic/hydrophilic conversion of mesoporous silica nanopores.Multifunctional Gold-Mesoporous Silica Nanocomposites for Enhanced Two-Photon Imaging and Therapy of Cancer Cells.The role of surface functionality in nanoparticle exocytosis.Crosstalk of Nanosystems Induced Extracellular Vesicles as Promising Tools in Biomedical Applications.Boosting the therapeutic efficiency of nanovectors: exocytosis engineering.Intra-mitochondrial biomineralization for inducing apoptosis of cancer cells.Dual role of HDAC10 in lysosomal exocytosis and DNA repair promotes neuroblastoma chemoresistance.Silica-based multifunctional nanodelivery systems toward regenerative medicineA versatile drug delivery system targeting senescent cellsThe role of surface functionalization of silica nanoparticles for bioimagingMesenchymal stem cells loaded with paclitaxel-poly(lactic--glycolic acid) nanoparticles for glioma-targeting therapy
P2860
Q35009134-30D99BCC-2D6E-4079-90AF-A815653D89BDQ35795900-21AC403F-BDD6-4D1C-A769-5CB44E08E70FQ37134029-09C774F2-F0F3-4E02-ACC3-F3F3E40B5363Q37670239-2B0E2AEB-34AE-41DE-ABC7-272EEB55C03BQ38557213-A1E99751-5D7E-4F71-BE3F-C7AA69FEC6A5Q38557482-8BC94713-A81D-408F-80F5-3BEF4B6A2E5AQ38586843-3986EC68-215C-437F-8F4A-E1E2DC3D0ADAQ38786580-13FC19F7-601E-4153-BDD3-2D186A56D2ABQ38852801-11210107-6FCD-4994-9D1B-38155D6CFB42Q38874863-17949273-EE6B-4CEB-A24A-52B9FE547D27Q41600610-C20951C7-D858-4097-91C3-BA14B5223963Q42151859-BAAC197C-19CA-4D7E-810A-0B74EDDD4616Q42544597-FD120A75-E0FF-4000-A54F-311A048725B4Q47359221-314F63DF-B57F-4C34-BF93-B9B22EF86207Q48163518-48B39863-8C28-4FD8-98D0-FEE44F549B2AQ55222222-9E75DD04-7530-45CA-BAD8-F63EFEB0271DQ55692299-2C23EA99-AFF0-4D1B-BA30-806E06DC45A2Q57367659-2CD0EFD5-09B2-43F2-ADBC-14B6BA9D67A1Q57688652-FB48EC79-C678-4F76-879A-462374C3C971Q57832986-8D00E656-762A-4787-9273-D98A1393DB01Q58759012-57033105-FB6B-4D8A-9E42-8BEEF967582A
P2860
Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Involvement of lysosomal exocy ...... fect by exocytosis inhibition.
@en
Involvement of lysosomal exocy ...... fect by exocytosis inhibition.
@nl
type
label
Involvement of lysosomal exocy ...... fect by exocytosis inhibition.
@en
Involvement of lysosomal exocy ...... fect by exocytosis inhibition.
@nl
prefLabel
Involvement of lysosomal exocy ...... fect by exocytosis inhibition.
@en
Involvement of lysosomal exocy ...... fect by exocytosis inhibition.
@nl
P2093
P2860
P921
P356
P1433
P1476
Involvement of lysosomal exocy ...... ffect by exocytosis inhibition
@en
P2093
Angela A Hwang
April D Pyle
Courtney R Thomas
Daniel P Ferris
Derrick Tarn
Fuyuhiko Tamanoi
Jeffrey I Zink
Rolando E Yanes
P2860
P304
P356
10.1002/SMLL.201201811
P577
2012-11-14T00:00:00Z